Participation of SND1 in molecular networks involving NF-κB signalling activation and miR-221 induction [23], miR-184 expression and JAK/STAT3 inhibition [21], TGFβ1/Smad signalling pathway [15], Wnt/β-catenin activation [17] as well as the interaction of SND1 with partner proteins like metadherin-1 [24] and monoglyceride lipase [16], have been described to strictly modulate prosurvival and proliferative genes and proteins expression in cancer cells. The gene discussed is SND1; the disease is cancer.